Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors

A current trend in the quest for new therapies for complex, multifactorial diseases, such as diabetes mellitus (DM), is to find dual or even multi-target inhibitors. In DM, the sodium dependent glucose cotransporter 2 (SGLT2) in the kidneys and the glycogen phosphorylase (GP) in the liver are valida...

Descripción completa

Detalles Bibliográficos
Autores principales: Sipos, Ádám, Szennyes, Eszter, Hajnal, Nikolett Éva, Kun, Sándor, Szabó, Katalin E., Uray, Karen, Somsák, László, Docsa, Tibor, Bokor, Éva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071193/
https://www.ncbi.nlm.nih.gov/pubmed/33920838
http://dx.doi.org/10.3390/ph14040364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071193/
https://www.ncbi.nlm.nih.gov/pubmed/33920838
http://dx.doi.org/10.3390/ph14040364

Ejemplares similares